Novartis delivered another strong quarter with double digit sales growth and core margin expansion; 2019 sales and profit guidance raised; Beovu launched in US

NEXT STORY
ASLAN Pharmaceuticals Enrolls First Patient in Proof-of-Concept Study for ASLAN004 Targeting Atopic Dermatitis
PREV STORY
NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Vaccine V920 (ERVEBO®)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Home Healthcare Markets Report 2020-2027: Size is Forecast to Reach $680.35 Bn – Increasing Investment in the Smart Monitoring Solutions and Tele-ICU

author_avatar
NASDAQ Market News

Cue Biopharma Reports First Quarter 2021 Results, Recent Updates of CUE-101 Phase 1 Dose Escalation Study, Platform Progress and Business Highlights

author_avatar
NASDAQ Market News

BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions

author_avatar
NASDAQ Market News